• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Has the time finally come to measure hsCRP universally in primary and secondary cardiovascular prevention?

作者信息

Ridker Paul M, Koenig Wolfgang, Kastelein John J, Mach François, Lüscher Thomas F

机构信息

Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Deutsches Herzzentrum München, Technische Universität München, DZHK (German Centre for Cardiovascular Research), partner site, Munich Heart Alliance, Munich, Germany.

出版信息

Eur Heart J. 2018 Dec 7;39(46):4109-4111. doi: 10.1093/eurheartj/ehy723.

DOI:10.1093/eurheartj/ehy723
PMID:30452612
Abstract
摘要

相似文献

1
Has the time finally come to measure hsCRP universally in primary and secondary cardiovascular prevention?在心血管疾病一级和二级预防中普遍检测高敏C反应蛋白（hsCRP）的时机终于到来了吗？
Eur Heart J. 2018 Dec 7;39(46):4109-4111. doi: 10.1093/eurheartj/ehy723.
2
Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a).高脂蛋白血症（a）患者心血管疾病的一级和二级预防
Clin Res Cardiol Suppl. 2017 Mar;12(Suppl 1):22-26. doi: 10.1007/s11789-017-0090-3.
3
JUPITER study highlights C-reactive protein as a cardiac risk factor.JUPITER研究强调C反应蛋白是一种心脏风险因素。
Cardiovasc J Afr. 2009 Mar-Apr;20(2):146.
4
Lipid Lowering Is Beneficial for Secondary Prevention but Not Primary Prevention in Patients 75 Years and Older.降脂对75岁及以上患者的二级预防有益，但对一级预防无益。
Am Fam Physician. 2021 Jun 1;103(11):695-696.
5
Cholesterol and inflammatory risk: Insights from secondary and primary prevention.胆固醇与炎症风险：二级和一级预防的见解
Atherosclerosis. 2019 Jan;280:192-193. doi: 10.1016/j.atherosclerosis.2018.10.009. Epub 2018 Oct 17.
6
New Approaches for the Prevention and Treatment of Cardiovascular Disease: Focus on Lipoproteins and Inflammation.防治心血管疾病的新方法：关注脂蛋白和炎症。
Annu Rev Med. 2021 Jan 27;72:431-446. doi: 10.1146/annurev-med-100119-013612. Epub 2020 Nov 20.
7
Editor's presentation.编辑的介绍。
Eur J Prev Cardiol. 2017 Jul;24(10):1011-1013. doi: 10.1177/2047487317709728.
8
Omega-3 polyunsaturated fatty acid in primary and secondary cardiovascular disease prevention.欧米伽-3多不饱和脂肪酸在原发性和继发性心血管疾病预防中的作用
AAOHN J. 2009 Nov;57(11):480. doi: 10.3928/08910162-20091027-05.
9
Secondary Prevention of Cardiovascular Diseases and Application of Technology for Early Diagnosis.心血管疾病的二级预防与早期诊断技术的应用。
Biomed Res Int. 2018 May 8;2018:5767864. doi: 10.1155/2018/5767864. eCollection 2018.
10
Aspirin for Primary and Secondary Prevention of Cardiovascular Disease.阿司匹林用于心血管疾病的一级和二级预防
Tex Heart Inst J. 2016 Aug 1;43(4):318-9. doi: 10.14503/THIJ-16-5807. eCollection 2016 Aug.

引用本文的文献

1
Integrating mental health and cardiovascular wellness: synergistic impacts and the promise of comprehensive care models.整合心理健康与心血管健康：协同影响及综合护理模式的前景。
Ann Med Surg (Lond). 2025 May 29;87(8):4963-4974. doi: 10.1097/MS9.0000000000003391. eCollection 2025 Aug.
2
Endothelial dysfunction in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: current knowledge and novel biomarkers.21-羟化酶缺乏所致先天性肾上腺皮质增生症中的内皮功能障碍：当前认知与新型生物标志物
Front Endocrinol (Lausanne). 2025 Jun 3;16:1581681. doi: 10.3389/fendo.2025.1581681. eCollection 2025.
3
Impact of Life's Essential Eight and Inflammatory Markers on Long-term Cardiovascular Disease Risk and All-cause Mortality: The Heart SCORE Study.
生命基本八项指标及炎症标志物对长期心血管疾病风险和全因死亡率的影响：心脏SCORE研究
medRxiv. 2025 Jun 3:2025.06.02.25328831. doi: 10.1101/2025.06.02.25328831.
4
Dissecting inflammation in the immunemetabolomic era.免疫代谢组学时代的炎症剖析
Cell Mol Life Sci. 2025 Apr 28;82(1):182. doi: 10.1007/s00018-025-05715-8.
5
Association Between Inflammation Indices Derived From Complete Blood Count and Coronary Artery Calcification.全血细胞计数得出的炎症指标与冠状动脉钙化之间的关联。
J Inflamm Res. 2025 Mar 13;18:3807-3816. doi: 10.2147/JIR.S501429. eCollection 2025.
6
Sheehan syndrome: a current approach to a dormant disease.希恩综合征：一种针对隐匿性疾病的当前治疗方法。
Pituitary. 2025 Jan 25;28(1):20. doi: 10.1007/s11102-024-01481-1.
7
Residual Traditional Risk in Non-Traditional Atherosclerotic Diseases.非传统动脉粥样硬化疾病中的残余传统风险。
Int J Mol Sci. 2025 Jan 10;26(2):535. doi: 10.3390/ijms26020535.
8
Monocyte to High-Density Lipoprotein Ratio Is Associated With Carotid Plaque: A Retrospective Cohort Study.单核细胞与高密度脂蛋白比值与颈动脉斑块相关：一项回顾性队列研究。
J Am Heart Assoc. 2025 Feb 4;14(3):e037210. doi: 10.1161/JAHA.124.037210. Epub 2025 Jan 23.
9
The therapeutic potential of Honeysuckle in cardiovascular disease: an anti-inflammatory intervention strategy.金银花在心血管疾病中的治疗潜力：一种抗炎干预策略。
Am J Transl Res. 2024 Dec 15;16(12):7262-7277. doi: 10.62347/NJMJ7853. eCollection 2024.
10
Chronic low-grade inflammation in patients with systemic sclerosis is associated with increased risk for arteriosclerotic cardiovascular disease.系统性硬化症患者的慢性低度炎症与动脉粥样硬化性心血管疾病风险增加相关。
Front Med (Lausanne). 2024 Nov 5;11:1446268. doi: 10.3389/fmed.2024.1446268. eCollection 2024.